Although the BCG vaccine may keep severe forms of tuberculosis, meningitis, and miliary tuberculosis at bay, its efficacy and effectiveness against pulmonary tuberculosis are low.
A vaccination campaign against meningococcal B bacteria has been initiated in the Chambéry and Lyon-East regions of France following an increase in infections with a new variant.